Advanced Search

803 KAR 25:280. Certification of drug-free workplace


Published: 2015

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
      803 KAR 25:280. Certification of

drug-free workplace.

 

      RELATES TO: KRS 13B.140, 217.900(1),

218A.010(6), 304.13-167, 342.011(9), 342.640, 342.660, 351.010(1)(m)

      STATUTORY AUTHORITY: KRS 304.13-167

      NECESSITY, FUNCTION AND CONFORMITY: KRS 304.13-167(6)

requires the Executive Director of the Office of Workers’ Claims to promulgate

administrative regulations regarding a drug-free workplace program for Kentucky

employers to implement. This administrative regulation establishes the

requirements for employers to apply and be certified by the Office of Workers’

Claims for implementing a drug-free workplace program.

 

      Section 1. Definitions. (1) "Alcohol"

means ethyl alcohol, hydrated oxide of ethyl, or spirit of wine, produced from

any source or process.

      (2) "Consortium" means an

entity, which may involve varied pools of employers and their employees,

established to provide cost-effective services to employers

to help the employers comply with drug-free workplace program requirements and

may provide employer education, supervisor training, and drug and alcohol testing

at a reduced cost to the employers who choose to participate.

      (3) "Drug" means a

controlled substance as defined in KRS 218A.010(6) and as established in 902

KAR Chapter 55, including:

      (a) Amphetamines;

      (b) Cannabanoids/THC;

      (c) Cocaine;

      (d) Opiates;

      (e) Phencyclidine (PCP);

      (f) Benzodiazepines;

      (g) Propoxyphene;

      (h) Methaqualone;

      (i) Methadone;

      (j) Barbiturates;

      (k) Synthetic narcotics;

      (l) Illicit substances; and

      (m) Volatile substances as defined by KRS 217.900(1).

      (4) "Drug or alcohol rehabilitation

program" means a service provider that provides confidential, timely, and

expert identification, assessment, treatment, and resolution of employee drug

or alcohol abuse.

      (5) "Drug test" or

"test" means a chemical, biological, or physical instrumental

analysis administered by a qualified laboratory, for the purpose of determining

the presence or absence of a drug or its metabolites or alcohol pursuant to standards, procedures,

and protocols established by the U.S. Department of Health and Human Services'

Substance Abuse and Mental Health Services Administration (SAMHSA), at http://www.workplace.samhsa.gov/.

      (6) "Employee" is defined by

KRS 342.640.

      (7) "Employee

Assistance Program" means an established program providing:

      (a) Professional assessment of employee

personal concerns;

      (b) Confidential and timely services to

identify employee alcohol or substance abuse;

      (c) Referrals of employees with alcohol

or substance abuse for appropriate diagnosis, treatment, and assistance; and

      (d) Follow-up services for employees who

participate in a drug

or alcohol rehabilitation program and are recommended for monitoring after

returning to work.

      (8) "Employer" means a corporation,

partnership, sole proprietorship, or other business entity doing business in Kentucky which is required to comply with the provisions of KRS Chapter 342 or voluntarily

covers excluded employees pursuant to KRS 342.660.

      (9) "Executive director" is defined by

KRS 342.0011(9).

      (10) "Illicit substance" is

defined by KRS 351.010(1)(m).

      (11) "Medical review officer"

or "MRO" means a licensed physician with knowledge of substance abuse

disorders, laboratory testing, chain of custody, collection procedures, the

ability to verify positive, confirmed test results, and the necessary medical

training to interpret and evaluate a positive test result in relation to the

person’s medical history or any other relevant biomedical information.

      (12) "Office" is defined by KRS

342.0011(8).

      (13) "Qualified laboratory"

means a laboratory certified in accordance with the National Laboratory

Certification Program (NLCP) by the United States Department of Health and

Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA).

      (14) "Reasonable suspicion

testing" means drug or alcohol testing that meets the requirements in

Section 3 of this administrative regulation.

      (15) "Serious physical injury" means

an injury which has a reasonable potential to cause death.

 

      Section 2. Applicability. (1) Employer

participation in the Drug-Free Workplace Program shall be voluntary.

      (2) All drug or alcohol testing shall be

conducted:

      (a) In accordance with applicable federal

and state requirements, as utilized in each part of the testing process; and

      (b) As required by this administrative

regulation for participants in the Drug-Free Workplace Program.

 

      Section 3. Requirements for a Drug-Free Workplace Program.

To obtain certification for a drug-free workplace program, an employer shall

comply with all of the following minimum requirements:

      (1) The program shall include alcohol and

substance abuse education and awareness training for employees and supervisors

which:

      (a) Provides to all employees written

materials explaining the employer’s policies and procedures with respect to the

drug-free workplace program;

      (b) Provides each employee at least one

(1) hour of initial, and at least thirty (30) minutes refresher each year

thereafter, of alcohol and substance abuse education and awareness training

which shall include, at a minimum, information concerning:

      1. Alcohol and drug testing;

      2. The effects of alcohol and drug use on

an individual’s health, work, and personal life;

      3. The disease of alcohol or drug

addiction;

      4. Signs and symptoms of an alcohol or

drug problem;

      5. The role of coworkers and supervisors

in addressing alcohol or substance abuse; and

      6. Referrals to an employee assistance

program; and

      (c)1. Provides all supervisory personnel,

in addition to the training specified in paragraph (b) of this subsection, with

thirty (30) minutes each year of alcohol and substance abuse education and awareness

training.

      2. The training shall include, at a

minimum, information on:

      a. Recognizing the signs of alcohol and

substance abuse in the workplace;

      b. How to document signs of employee

alcohol or substance abuse;

      c. How to refer employees to an employee

assistance program or other alcohol and substance abuse treatment; and

      d. Legal and practical aspects of

reasonable suspicion testing for the presence of drugs and alcohol;

      (2) Within the program, reasonable

suspicion testing shall be based on a belief that an employee is using or has

used drugs or alcohol in violation of the employer’s policy, drawn from

specific objective and articulable facts and reasonable inferences drawn from

those facts in light of experience, training, or education. The reasonable

suspicion testing shall be based upon:

      (a) While at work, direct observation of

drug or alcohol use or of the physical symptoms or manifestations of being

under the influence of a drug or alcohol;

      (b) While at work, abnormal conduct,

erratic behavior, or a significant deterioration in work performance;

      (c) A report of drug or alcohol use

provided by a reliable and credible source;

      (d) Evidence that an individual has

tampered with a drug or alcohol test during employment with the current covered

employer;

      (e) Information that an employee has

caused, contributed to, or been involved in an accident while at work; or

      (f) Evidence that an employee has used,

possessed, sold, solicited, or transferred illegal or illicit drugs or used

alcohol while on the covered employer’s premises or while operating the covered

employer’s vehicle, machinery, or equipment;

      (3) The program shall include breath

alcohol and urine drug testing to which job applicants or employees shall be

required to submit at the following times:

      (a) For urine drug testing:

      1. After conditional offer of employment;

      2. After being selected using a

statistically valid, unannounced random method;

      3. Upon reasonable suspicion of

prohibited drug use;

      4. At follow-up testing at least once per

quarter for one (1) year after the employee’s successful completion of an

employee assistance program for drug-related problems, or a drug rehabilitation

program, or as recommended by the person administering the drug rehabilitation

program; and

      5. Following an accident on the premises

of the employer or in the course of employment for the employer which requires

off-site medical attention be given to a person.

      (b) For breath alcohol testing:

      1. After conditional offer of employment;

      2. Upon reasonable suspicion of

prohibited alcohol use;

      3. Following an accident on the premises

of the employer or in the course of employment for the employer which requires

off-site medical attention be given to a person; and

      4. Follow-up testing at least once per

quarter for one (1) year after the employee's successful completion of an

employee assistance program for alcohol-related problems, or an alcohol

rehabilitation program, or as recommended by the person administering the

alcohol rehabilitation program;

      (4) The office may issue a certification

for a program that provides for alcohol and drug testing of other fluids or products

of the human body capable of revealing the presence of drugs or alcohol if the

testing is as accurate as, and equivalent to, breath alcohol and urine drug

testing and complies with this section of this administrative regulation;

      (5) The program shall include the minimum

testing protocol which shall include:

      (a) A maximum acceptance level of breath

alcohol concentration, which shall be a concentration of four-hundredths

(0.04); and

      (b) An eleven (11) panel urine test that

shall include testing for the following substances:

      1. Amphetamines;

      2. Cannabanoids/THC;

      3. Cocaine;

      4. Opiates;

      5. Phencyclidine (PCP);

      6. Benzodiazepines;

      7. Propoxyphene;

      8. Methaqualone;

      9. Methadone;

      10. Barbiturates; and

      11. Synthetic narcotics;

      (6) The program shall provide that the

collection of samples and administration of drug and alcohol tests shall follow

all standards, procedures and protocols set forth by the U.S. Department of

Health and Human Services’ Substance Abuse and Mental Health Administration

(SAMHSA), at http://www.workplace.samhsa.gov/;

      (7) The program shall provide that the

test results have been performed by a qualified laboratory;

      (8) The program shall include medical

review of test results as follows:

      (a)1. All test results shall be submitted

for medical review by the medical review officer (MRO), who shall consider the

medical history of the employee or applicant, as well as other relevant

biomedical information.

      2. If there is a positive test result,

the employee or applicant shall be given an opportunity to report to the MRO

the use of any prescription or over-the-counter medication.

      (b)1. If the MRO determines that there is

a legitimate medical explanation for a positive test result, the MRO shall

certify that the test results do not indicate the unlawful use of alcohol or a

controlled substance.

      2. If the MRO

determines, after appropriate review, that there is not a medical explanation

for the positive test result other than the unauthorized use of alcohol or a

prohibited drug, the MRO shall refer the individual tested

to an employee assistance program or to a personnel or administrative officer

for further proceedings in accordance with the employer’s drug-free workplace

program.

      (c) Determinations

concerning the use of alcohol or a controlled or illicit substance shall comply

with all procedures outlined in the U.S. Department of Health and Human

Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) "Medical

Review Officer Manual for Federal Agency Workplace Drug Testing Programs";

      (9) The program shall include an employee

assistance program (EAP) for its employees and supervisory personnel.

      (a) The employer shall:

      1. Establish the EAP as a part of its

internal personnel services; or

      2. Contract with an entity that provides

EAP services.

      (b) The employer's participation in a

consortium shall satisfy this requirement; and

      (10) The program shall include

controlled-access maintenance at the employer’s place of business of records

including the names and position titles of all employees and supervisory

personnel trained under the program, and the names of all persons who presented

alcohol and substance abuse training, for review by the office.

 

      Section 4. Confidentiality of records. Records of

drug or alcohol test results, written or otherwise, received by the employer

shall be confidential communications and shall not be disclosed by the employer

to any party unless:

      (1) A written release of information is

granted and signed by the employee; or

      (2) The release is ordered by a court of

competent jurisdiction.

 

      Section 5. Application Requirements.

Employers who desire a drug-free workplace certification pursuant to KRS 304.13-167

shall submit to the office an initial notarized application, and annually thereafter,

in the form of an affidavit executed by the owner or chief executive officer of

the business establishing that it provides a drug-free workplace by:

      (1) Providing a copy of a statement to

each employee and posting the statement in a prominent place at each worksite. The

statement shall:

      (a) Notify employees that the unlawful

manufacture, distribution, dispensation, possession, or use of alcohol or a controlled

or illicit substance is prohibited in the workplace;

      (b) Identify methods that may be used by

the employer to determine if violations by an employee exists; and

      (c) Specify the actions that will be

taken against employees for violations of the prohibition;

      (2) Establishing an alcohol and substance

abuse education and awareness training program which complies with the minimum

requirements of Section 3 of this administrative regulation to inform employees

and supervisory personnel about:

      (a) The dangers of drug abuse in the

workplace;

      (b) The role of co-workers and

supervisors in addressing alcohol or drug abuse;

      (c) The employer’s policy of maintaining

a drug-free workplace;

      (d) Available drug counseling,

rehabilitation, and employee assistance programs; and

      (e) The penalties for violations of the

drug-free workplace policy;

      (3) Establishing a program that includes

alcohol and drug testing performed as established in Section 3 of this administrative

regulation;

      (4) Providing an Employee Assistance

Program which shall:

      (a) Include:

      1. Professional assessment of employee

personal concerns;

      2. Confidential and timely services to

identify employee drug or alcohol abuse;

      3. Referrals of employees for appropriate

diagnosis, treatment, and assistance with regard to employee alcohol or

substance abuse; and

      4. Follow-up services for employees who

participate in a drug

or alcohol rehabilitation program and are recommended for monitoring after

returning to work; and

      (b) Provide services regardless of race,

color, religion, national origin, disability, sex, or age;

      (5) Verifying that the frequency and

duration of each employee and supervisor training session meets the

requirements of Section 3 of this administrative regulation;

      (6) Verifying that all employees have

participated, or shall participate during the calendar year, in the required

alcohol and substance abuse education and awareness training sessions;

      (7) Maintaining a drug-free workplace throughout

its workers’ compensation insurance policy period; and

      (8) Maintaining the drug-free workplace

program in compliance with all federal and state laws and regulations that

apply to that particular business.

 

      Section 6. Required Documentation. (1) An

employer’s initial application shall be accompanied by copies of the following

documents:

      (a) The employer’s written drug-free

workplace policy;

      (b) Documents provided to employees

regarding the drug-free workplace program if different from the policy; and

      (c) The following, if not included in the

drug-free workplace policy:

      1. A statement identifying each alcohol

and drug test that will be conducted;

      2. A statement describing the employer’s

Employee Assistance Program;

      3. A description of the alcohol and

substance abuse education and awareness training program for employees and

supervisory personnel; and

      4. A statement describing the

confidentiality of the employer’s drug-free workplace program.

      (2) Employers shall attach the documents

listed in subsection (1) to a renewal application only if a substantive change

or amendment has been made to the material filed with the initial application.

 

      Section 7. Certification of Drug-Free

Workplace Procedure. (1)(a) If the office receives an incomplete application of

certification of drug-free workplace, the office shall notify an employer in

writing of an incomplete application and shall state the necessary information

or documents to provide a complete review of the application;

      (b) The employer shall provide the

additional information and documents within fifteen (15) days of the notification

of an incomplete application; and

      (c) If the employer fails to provide the

requested information, the application shall be denied.

      (2)(a) Within sixty (60) days of receipt

of a complete application, the office shall issue a written statement to the

applicant approving or denying the application; and

      (b) If the application is denied, the

written notification shall specifically state the reasons for the denial.

      (3) The notification of approval or

denial shall be mailed by certified mail, return receipt requested to the

address listed on the application.

      (4)(a) If an employer, who has been

certified to have a drug-free workplace program, discontinues or fails to maintain

its program in compliance with this administrative regulation, the office shall

revoke the employer’s certification.

      (b) The office shall submit written

notification of the revocation which shall:

      1. Include specific reasons for the

revocation; and

      2. Shall be mailed by certified mail,

return receipt requested, to the address listed on the employer’s

certification.

      (5) Service by certified mail shall be

complete:

      (a) Upon delivery of the notification;

      (b) Upon acceptance by any person

eighteen (18) years or older at the employer address;

      (c) Upon refusal to accept by a person at

the employer’s address;

      (d) Upon the U.S. Postal Service’s

inability to deliver the notification if properly addressed; or

      (e) Upon failure of the applicant to

claim the notification prior to its return to the office by the U.S. Postal

Service.

      (6) The return receipt or envelope shall

be proof of acceptance, refusal, inability to deliver, or failure to claim the

envelope.

 

      Section 8. Denial or Revocation of Certification.

(1) If an employer’s application for certification is denied or revoked, an

employer may request, in writing, a hearing before the executive director on

the denial or revocation of certification;

      (2) The request for a hearing shall be

filed with the office within twenty (20) days from the date of the notice of

denial or revocation;

      (3) Upon receipt of a request for a

hearing, the executive director shall issue a notice of hearing to be held no

sooner than ten (10) days and no later than thirty (30) days after the request unless

agreed to by the parties;

      (4) No later than thirty (30) days after

the hearing is closed, the executive director shall issue a written order concerning

all matters addressed at the hearing; and

      (5) The executive director’s final order

may be appealed to the Franklin Circuit court in accordance with KRS 13B.140.

 

      Section 9. Incorporation by Reference. (1)

The following material is incorporated by reference:

      (a) Form DFW, "Applicant’s

Affidavit: Drug-Free Workplace Program", (Sept. 2007 edition); and

      (b) The "Medical Review Officer

Manual for Federal Agency Workplace Drug Testing Programs", issued by the

Department of Health and Human Services, November 1, 2004 edition (DHHS Publication

No. (Administrative Regulation) 88-1526).

      (2) This material may be

inspected, copied, or obtained, subject to applicable copyright law, at the

Office of Workers’ Claims, 657 Chamberlin Avenue, Frankfort, Kentucky 40601, Monday through Friday, 8 a.m. to 4:30

p.m. (34 Ky.R. 1597; 2399; eff. 6-6-2008.)